The global animal model market is estimated to garner a revenue of around USD 1,943.3 million in 2024. Animals possess a shorter life cycle, a high genotype resemblance, and are easy to test in laboratories.
As per the animal model demand analysis report, the overall market is predicted to grow at a moderate CAGR of 6.0% over the next ten years. The report also forecasts the global animal model industry to reach a value of nearly USD 3,476.8 million by the end of this forecast period.
Animal Model Market Trends and Analysis:
| Report Attribute | Details |
|---|---|
| Animal Model Market Revenue (2024) | USD 1,943.3 million |
| Market Anticipated Forecast Value (2034) | USD 3,476.8 million |
| Market Projected Growth Rate (2024 to 2034) | 6.0% |
In 2019, the net revenue generated by animal model suppliers and service providers was assessed to be around USD 1,425 million. The global animal model market witnessed a growth rate of 6.4% from 2019 to 2023.
During this period, the animal model market had been facing tremendous pressure from animal welfare organizations and activists in various countries. However, the situation has changed drastically since the outbreak of COVID-19. This change in situation was due to animal model testing being central in research towards developing an effective vaccine against novel coronavirus or other pathogens.
| Historical Market CAGR (2019 to 2023) | 6.4% |
|---|---|
| Forecasted Market CAGR (2024 to 2034) | 6% |
The industry also received a significant fillip during this period due to a rapid rise in demand for non-human primates for research into COVID-19 vaccines. This research is expected to continue in the near future, driving the demand for different species for preclinical models.
Alternatives such as cell cultures, tissue cultures, and computer models are also available. However, animal models are preferred owing to the complexity of the living systems. Significant incidence rates of diseases, along with adverse effects of drugs, have driven the adoption of animal models to ensure the safety of humans. So, the persisting demand for laboratory animals in pharmacological studies is expected to strengthen the market with the expansion of the pharmaceutical sector.
Pharmacological studies, which include target identification & validation, toxicology drug screening & lead optimization & safety screening, have also surged the demand for advanced animal models for preclinical research. For instance, according to the Pharmaceutical Research and Manufacturers of America, biopharmaceutical businesses spent roughly USD 79.6 billion on research and development in the United States in 2018.
Government intervention in academic and research institutions is increasing for the development of standard protocols related to animal models. Researchers utilize animal models for basic research, such as developing new therapeutic strategies to treat human diseases and preclinical analyses of developed drug safety & efficacy. Moreover, continued advances in animal models, the availability of modern healthcare systems, and a considerable increase in demand for modern healthcare facilities are also expected to propel the market to some degree.
One of the major restraints in the adoption of some animal models is the risk of researchers using animal models being susceptible to false analogy, where implications built around assumptions of similarities between animals and humans can potentially lead to an incorrect conclusion.
The table below puts together the CAGRs for a few countries expected to witness a notable increment in their share of the animal model industry. In North American and European countries witness robust growth rates with relevant policies being reformed by the government to spur funding plans related to animal model research. Several animal model solution providers in Asia are also expected to make huge investments in biogenic research which is reflected in the promising growth rates of China and Japan.
| Regional Market Comparison | CAGR (2024 to 2034) |
|---|---|
| United States | 6.7% |
| Germany | 8.2% |
| United Kingdom | 6.6% |
| Japan | 4.7% |
| China | 6.1% |
The demand for experimental animals in the United States for in vivo models is predicted to increase 6.7% through the projected years. The United States is likely to be a dominating country in the animal model market because of
The market in China holds a significant share of the global market and is likely to maintain its dominance in Asia for laboratory animals for pharmacological studies. Some prominent factors that are expected to drive the China market at 6.1% CAGR through the forecast period include:
Based on species, revenue from rat-based animal models is estimated to account for a 37.3% market share in 2024.
| Attributes | Details |
|---|---|
| Top Species Type or Segment | Rats |
| Market Share in 2024 | 37.3% |
Revenue from the use of rats in animal models is also slated to expand through the forecasted years due to the following reasons:
The development of animal models for drug discovery is expected to account for nearly 54.4% of the market share in 2024.
| Attributes | Details |
|---|---|
| Top Application Type | Drug Discovery and Development |
| Market Share in 2024 | 54.4% |
A few key factors that are expected to retain the dominance of the drug discovery and development segment through the forecast years include:
Key animal model system providers are focusing on strategic acquisitions, mergers, collaborations, and partnerships to grow their client base and boost their industrial position. Recent investments by leading companies have created prospects for the market to expand globally.
The market is now highly influenced by technological interventions in software modeling for time and cost efficiency, along with the growing ethical concerns in reducing the number of live animals used for research. Recent key developments in the market include the development of a novel monkey research model using CRISPR technology.
Recent Developments in the Global Animal Model Market
In January 2020, Horizon Discovery Group plc. confirmed a partnership and license deal with Mammoth Biosciences to gain access to Mammoth's unique CRISPR technology. The partnership is expected to make it easier for Horizon to provide a new generation of genetically altered CHO cells to manufacture biotherapeutics such as therapeutic antibodies.
In March 2022, Charles River Laboratories and Hera Biolabs inked a contract for the breeding, marketing, and sales of SRG rats to the world's preclinical research community. Through this deliberate partnership, Hera BioLabs is aiming to expand the geographic reach of its highly immunodeficient rat model.
| Report Attributes | Details |
|---|---|
| Current Total Market Size (2024) | USD 1,943.3 million |
| Projected Market Size (2034) | USD 3,476.8 million |
| CAGR (2024 to 2034) | 6.0% |
| Base Year for Estimation | 2023 |
| Historical Period | 2019 to 2023 |
| Projections Period | 2024 to 2034 |
| Quantitative Units | USD million for value and thousand units for volume |
| Species Types Analyzed (Segment 1) | Rats, Mice, Guinea Pigs, Rabbits, Monkeys, Dogs, Pigs, Cats, Other Species |
| Applications Analyzed (Segment 2) | Basic and Applied Research, Drug Discovery and Development, Other Applications |
| End Users Analyzed (Segment 3) | Academic & Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Other End Users |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East & Africa |
| Countries Covered | United States, Canada, Mexico, Brazil, Argentina, Germany, France, United Kingdom, Italy, Spain, Netherlands, China, India, Japan, South Korea, ANZ, GCC Countries, South Africa |
| Key Players influencing the Animal Model Market | Charles River Laboratories International, Inc., Horizon Discovery Group plc, The Jackson Laboratory, Taconic Biosciences, Inc., Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc., Envigo CRS SA, Transposagen Biopharmaceuticals, Inc. |
| Additional Attributes | Increased demand for transgenic models in oncology and immunology, Trends in CRO outsourcing for animal testing, Regulatory advancements for ethical animal model use, Technological improvements in genome editing and phenotype replication |
| Customization and Pricing | Customization and Pricing Available on Request |
The global animal model market is estimated to be valued at USD 1,943.3 million in 2024.
The global animal model market is to grow at 6.0% during the forecast period.
The global animal model market is predicted to be valued at USD 3,476.8 million by 2034.
The United States accounts for over one-fourth revenue share of the global market.
Germany is predicted to witness an 8.2% CAGR in the adoption of animal models through 2034.
Explore Life Science & Biotechnology Insights
Animal Model Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
